Catherine Eckford2025-09-05T12:43:00
The regulator’s new principles aim to ease the pathway to regulatory approval for rare disease drug developers in the US.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-09-04T08:58:00Z
Sponsored by PCI Pharma Services, David O’Connell
2026-06-29T06:00:00
Sponsored by Lubrizol Advanced Materials Europe BV
2026-04-30T10:37:00
Sponsored by Shimadzu
2026-03-27T15:37:00
Sponsored by IMA Pharma
2026-07-13T07:00:00
Sponsored by Thermo Fisher Scientific
2026-09-02T14:00:00
Sponsored by FUJIFILM Wako Chemicals Europe GmbH
2025-09-19T15:46:00
Sponsored by ACCI, European Pharmaceutical Review
Site powered by Webvision Cloud